ADVISORY/ Agencourt Bioscience to Present New High-throughput SNP Discovery and Genotyping Approach.Business Editors and Health/Medical Writers ADVISORY...for Monday (Aug. 5) Drug Discovery Technology 2002 Conference --(BUSINESS WIRE) Former Whitehead Institute Founded in 1982, the Whitehead Institute for Biomedical Research is a non-profit research and teaching institution located in Cambridge, Massachusetts. The Whitehead Institute was founded as a fiscally independent entity from Massachusetts Institute of Technology, and its members Scientist and Agencourt Founder to Address Major Drug Discovery Technology Conference Paul McEwan Paul Ernest McEwan (born in Christchurch, New Zealand on December 19, 1953) is a former Canterbury and New Zealand cricketer who played in 4 Tests and 17 ODIs from 1980 to 1985. , Vice President and Co-Chief Scientific Officer for Agencourt Bioscience Corporation, will present a poster session titled, "A Streamlined System for SNP SNP Scottish National Party Noun 1. SNP - (genetics) genetic variation in a DNA sequence that occurs when a single nucleotide in a genome is altered; SNPs are usually considered to be point mutations that have been evolutionarily Discovery and Genotyping," at Drug Discovery Technology 2002 Conference at the Hynes Convention Center The John B. Hynes Veterans Memorial Convention Center located in Boston's Back Bay has 193,000 square feet (0 m) of exhibit space and can accommodate up to four concurrent events. in Boston, Mass. on August 4-9, 2002. McEwan will present a new method for addressing the growing need in the life sciences community for high-throughput and directed SNP discovery work to fully understand the correlation between SNPs and diseases. SNP research is increasingly required for pharmacogenomics studies focusing on candidate genes suspected in playing a role in a particular genetic association. When exposing the role of genetic variations in common disease and drug efficacy, the first step is the discovery of SNP markers across the genome. More than 2.1 million identified SNPs, which are in public databases, are randomly distributed throughout genomes with a low probability of having high-density SNP markers in specific regions of interest. Agencourt Bioscience's SeeSNP(TM) Discovery program utilizes an integrated informatics and laboratory pipeline that relies on a high-throughput resequencing strategy to assist with SNP discovery work. SNP loci loci [L.] plural of locus. loci Plural of locus, see there identified during the discovery process can be seamlessly advanced into Agencourt's AgenType(TM) Genotyping service. The AgenType service is based on high-throughput, MALDI-TOF MALDI-TOF Matrix Assisted Laser Desorption Ionization - Time of Flight mass spectometry, the most accurate genotyping technology available. This service helps pharmaceutical companies screen patient populations of clinical trials for genetic predispositions to drug response. Agencourt Bioscience Corporation is a provider of genomic services and products such as DNA Sequencing, SNP Genotyping and DNA DNA: see nucleic acid. DNA or deoxyribonucleic acid One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. Purification to the life sciences industry. Agencourt's solutions help biotech and pharmaceutical companies improve the effectiveness and efficiency of their drug development pipelines. The company's proven and patented Solid Phase Reversible Immobilization Immobilization Definition Immobilization refers to the process of holding a joint or bone in place with a splint, cast, or brace. This is done to prevent an injured area from moving while it heals. (SPRI SPRI Scott Polar Research Institute (University of Cambridge) SPRI Single Ply Roofing Institute SPRI Schering-Plough Research Institute (Corporate division) (TM)) technology has been used to sequence over 20 billion base pairs of high-quality DNA or more than one-third of the human genome. Several of Agencourt's founders worked at the Whitehead Institute Center for Genome Research, and have significant experience in marrying the chemistries and instrumentation for high-throughput genomics. For more information about Agencourt, please visit www.agencourt.com. WHO: Paul McEwan, Vice President, Co-Chief Scientific Officer, Co-Founder, Agencourt Bioscience WHAT: Poster Presentation: "A Streamlined System for SNP Discovery and Genotyping" WHERE: Drug Discovery Technology 2002 Conference Hynes Convention Center in Boston, Mass. WHEN: August 4-9, 2002 |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion